What Are The Risk Factors For Axonics Inc. (AXNX)?

0
4

As of Wednesday close, Axonics Inc.’s (NASDAQ:AXNX) stock was up $1.54, moving up 2.43 percent to $64.96. The average number of shares traded per day over the past five days has been 392,540 shares. 3 times new highs have been achieved over the past 5 days, with a $2.06 gain in that time frame. In the last twenty days, the average volume was 626,715, while in the previous 50 days, it was 604,456.

Since last month, AXNX stock retreated -8.70%. Shares of the company fell to $59.20 on 11/08/22, the lowest level in the past month. A 52-week high of $79.92 was reached on 09/15/22 after having rallying from a 52-week low of $38.41. Since the beginning of this year, AXNX’s stock price has risen by 16.00% or $8.96, and marked a new high 20 times. However, the stock has declined by -18.71% since its 52-week high.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


AXNX stock investors should be aware that Axonics Inc. (AXNX) stock had its last reported insider trading activity 72 days ago on Sep 13. Dearen Danny L., the of the company, disposed of 656 shares for $75.60 on Sep 13. It resulted in a $49,594 divestment by the insider. Noblett Karen sold 32,483 shares at an average price of $78.16 on Sep 12. The insider now owns 31,599 shares following the transaction. On Sep 08, Chief Marketing Officer Woock John sold 7,500 shares at $75.00 apiece. The transaction was valued at $562,524.

Valuation Metrics

The stock’s beta is 0.41. Besides these, the trailing price-to-sales (P/S) ratio of 13.18, the price-to-book (PB) ratio of 5.58.

Financial Health

In the three months ended June 29, Axonics Inc.’s quick ratio stood at 6.40, while its current ratio was 7.40, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 70.60% percent. In the year ended June 29, operating margins totaled -32.80%. Based on annual data, AXNX earned $115.72 million in gross profit and brought in $180.29 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -15.00%. Return on equity (ROE) for the past 12 months was -15.60%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. AXNX’s revenue rose 33.35% to $68.98 million during the quarter, while net income inched up to $70.38 million. While analysts expected Axonics Inc. to report -$0.54 quarterly earnings, the actual figure was -$0.47 per share, beating the consensus estimate by 13.00%. During the quarter, the company generated -$13.45 million in EBITDA. The liabilities of Axonics Inc. were 82.76 million at the end of its most recent quarter ended June 29, and its total debt was $9.75 million. The value of shareholders’ equity is $49.53 million.

Technical Picture

This quick technical analysis looks at Axonics Inc.’s (AXNX) price momentum. With a historical volatility rate of 34.51%, the RSI 9-day stood at 52.69% on 23 November.

With respect to its five-day moving average, the current Axonics Inc. price is up by +3.28% percent or $2.06. At present, AXNX shares trade -9.27% below its 20-day simple moving average and +7.84% percent above its 100-day simple moving average. However, the stock is currently trading approximately -15.80% below its SMA50 and +23.87% above its SMA200.

Stochastic coefficient K was 57.98% and Stochastic coefficient D was 44.46%, while ATR was 2.95. Given the Stochastic reading of 84.96% for the 14-day period, the RSI (14) reading has been calculated as 48.45%. As of today, the MACD Oscillator reading stands at 0.52, while the 14-day reading stands at 0.93.

With a median target price of $90.00, the current consensus forecast for the stock is $75.00 – $100.00. Based on these forecasts, analysts predict Axonics Inc. (AXNX) will achieve an average price target of $87.33.

LEAVE A REPLY

Please enter your comment!
Please enter your name here